Rankings
▼
Calendar
JBIO Q4 2024 Earnings — Jade Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
JBIO
Jade Biosciences, Inc.
$491M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$8,000
Operating Income
-$6M
Net Income
-$5M
EPS (Diluted)
$-6.56
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$80M
Total Liabilities
$4M
Stockholders' Equity
$76M
Cash & Equivalents
$34M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$8,000
-$28,000
+71.4%
Operating Income
-$6M
-$22M
+71.0%
Net Income
-$5M
-$20M
+73.4%
← FY 2024
All Quarters
Q1 2025 →